Tinlorafenib
Modify Date: 2024-01-10 18:29:09
Tinlorafenib structure
|
Common Name | Tinlorafenib | ||
|---|---|---|---|---|
| CAS Number | 2573781-75-4 | Molecular Weight | 456.89 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H19ClF2N4O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TinlorafenibTinlorafenib (PF-07284890) (compound 10) is an orally active BRAF kinase inhibitor, with IC50s of 4.25 and 2.7 nM for BRAFV600E/V600K respectively. Tinlorafenib demonstrates CNS penetration and can be used in the research of BRAF-associated malignant and benign tumors of the CNS as well as extracranial malignancies[1]. |
| Name | Tinlorafenib |
|---|
| Description | Tinlorafenib (PF-07284890) (compound 10) is an orally active BRAF kinase inhibitor, with IC50s of 4.25 and 2.7 nM for BRAFV600E/V600K respectively. Tinlorafenib demonstrates CNS penetration and can be used in the research of BRAF-associated malignant and benign tumors of the CNS as well as extracranial malignancies[1]. |
|---|---|
| Related Catalog | |
| Target |
BRafV600E:4.25 nM (IC50) BRafV600K:2.7 nM (IC50) |
| References |
| Molecular Formula | C19H19ClF2N4O3S |
|---|---|
| Molecular Weight | 456.89 |